United States · Venture startup

Who invested in Celeris Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI

Funding summaryUpdated 26 Oct 2026

$9.8Mraised across 1 round since 2022, from 1 source

Latest round
Venture, $9.8MOct 2022
Investors
1
See who backed them

The rounds

  1. Oct 2022
    Venture$9.8M

    Source recorded

Founders and team

From the SEC filings it signed: 2 on the team.

  • Christopher TrummerExecutive Officer, Directori
  • Jakob-Ferdinand HohenbergerExecutive Officer, Directori

On the board, as filediKarel KubiasMarius SwartPetr Sramek

Everyone who backed them

EIC AcceleratorGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Celeris Therapeutics

Who invested in Celeris Therapeutics?

Celeris Therapeutics's investors include EIC Accelerator.

How much has Celeris Therapeutics raised?

Celeris Therapeutics has raised $9.8M across 1 round since 2022.

When did Celeris Therapeutics last raise?

Celeris Therapeutics's most recent round was a Venture of $9.8M in Oct 2022.

What was Celeris Therapeutics's biggest round?

Its most recent round, $9.8M in Oct 2022, is also its largest on record.

Who backed Celeris Therapeutics first?

Celeris Therapeutics's first round on record, in Oct 2022, was backed by EIC Accelerator.

What stage is Celeris Therapeutics at?

Celeris Therapeutics's latest named round is a Venture, in Oct 2022.

Where is Celeris Therapeutics based?

Celeris Therapeutics is based in the United States.

Companies like Celeris Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.